CrushSCI.com
262.7Average days
258Median days
71Fastest days
529Longest days
1712025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

529 days

Systemic delivery of phagocytosis-shielded retroviral vectors enables in vivo HSC gene therapy for sickle cell disease

Authors
Denise Klatt; Adele Mucci; Boya Liu; Marie Peschers; Giulia Schiroli; Axel Schambach; John Manis; Myriam Armant; David T. Scadden; Els Verhoeyen; Danilo Pellin; David A. Williams; Christian BrendelShow moreShow less
Affiliations
Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA 02115, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; Institute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany; Department of Laboratory Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA; Therapeutic Innovation Lab, Boston Children’s Hospital, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; CIRI – International Center for Infectiology Research, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon, 69007, Lyon, France; Université Côte d'Azur, Centre Méditerranéen de Médecine Moléculaire, Nice, FranceShow moreShow less
Source PDF DOI Publisher page
264 days

H3K27M drives OPC stemness and intrathecal therapeutic vulnerability in brainstem glioma organoids

Authors
Luyang Xie; Zhuang Jiang; Hang Zhou; Xiaoxue Zhu; Yibo Geng; Mingxin Zhang; Tengxian Guo; Ge Shen; Xiaoyan Li; Ligong Chen; Gairong Zhang; Changwen Xue; Tuozhang Li; Xixi Zheng; Yaqi Wang; Haitao Fu; Yuxuan Deng; Jingfeng Li; Kai Jiang; Wenhao Wu; Peng Zhang; Changcun Pan; Shaobo Shan; Yujie Tang; Huan Li; Liang Wang; Zhen Wu; Cheng Xu; Liwei ZhangShow moreShow less
Affiliations
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China; Chinese Institutes for Medical Research, Beijing 100070, China; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China; Department of Neurosurgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China; Department of Neurosurgery, Beijing Fengtai Hospital, Beijing 100070, China; Department of Radiotherapy and Oncology, Beijing Fengtai Youanmen Hospital, Beijing 100068, China; Department of Oncology, Beijing Huian Hospital of Integrated TCM and Western Medicine, Beijing 100068, China; Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100700, China; State Key Laboratory of Membrane Biology, School of Pharmaceutical Sciences, Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology (Ministry of Education), Tsinghua University, Beijing 100084, China; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China; Department of Paediatrics and Adolescent Medicine, The Hong Kong Children’s Hospital, Hong Kong 999077, China; Beijing WellGene Biotech Co., Ltd., Beijing 102200, China; Key Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education, Shanghai Key Laboratory of Reproductive Medicine, Department of Histoembryology, Genetics and Developmental Biology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; China National Clinical Research Center for Neurological Diseases, Beijing 100070, China; Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, ChinaShow moreShow less
Source PDF DOI Publisher page
71 days

Clinical base editing for β-hemoglobinopathies across different genetic backgrounds

Authors
Rongrong Liu; Yongrong Lai; Lijie Wang; Xiaowen Qian; Xu-Kai Ma; Yaliang Li; Gaohui Yang; Lingling Shi; Zifeng Li; Jia Wei; Zhenbin Wei; Hongsheng Wang; Xuemei Zhou; Ling Yu; Bei Yang; Xiaowen Zhai; Xiaodun Mou; Li Yang; Jia ChenShow moreShow less
Affiliations
Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, China; NHC Key Laboratory of Thalassemia Medicine, Nanning 530021, Guangxi, China; Guangxi Key laboratory of Thalassemia Research, Nanning 530021, Guangxi, China; Gene Editing Center, School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China; CorrectSequence Therapeutics, Shanghai 201210, China; Department of Hematology and Oncology, Children’s Hospital of Fudan University, Shanghai 201102, China; Center for Molecular Medicine, Children’s Hospital of Fudan University and Shanghai Key Laboratory of Medical Epigenetics, International Laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Shanghai Key Laboratory of Gene Editing and Cell Therapy for Rare Diseases, Fudan University, Shanghai 200032, China; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, China; Shanghai Clinical Research and Trial Center, Shanghai 201210, China; Shanghai Academy of Natural Sciences (SANS), ShanghaiTech University, Shanghai 201210, ChinaShow moreShow less
Source PDF DOI Publisher page
163 days

Epi-Allele elicits compensatory expression of the non-targeted allele and prevents haploinsufficiency in dominant genetic diseases

Authors
Zhengmin Wang; Chengzhi Han; Yiming Huang; Yuyuan Fu; Kaijie Hu; Zheyong Huang; Weiying Meng; Qiyao Chen; Leilei Wu; Qiaozi Wang; Jinyan Zhang; Hao Luo; Yifan Wang; Lulu Zuo; Yingqi Li; Yiwen Tan; Qin Zhou; Shaoshuai Mao; Wenbo Peng; Juan Meng; Maoxiang Chen; Zhiyang Tian; Shuwei Chen; Zihan Hu; Lu Zhao; Yihan Shen; Shanshan Chen; Zhixin Shen; Lijuan Mo; Jinfeng Gao; Qiyu Li; Shiteng Cai; Jianhuang Xue; Yanan Song; Yidi Sun; Junbo Ge; Changyang ZhouShow moreShow less
Affiliations
Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200031, China; Institute of Neuroscience, State Key Laboratory of Genetic Evolution & Animal Models, CAS Center for Excellence in Brain Science and Intelligence Technology, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China; State Key Laboratory of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai 200031, China; Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Tongji Hospital affiliated to Tongji University, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China; Epigenic Therapeutics, Inc., Shanghai 201315, China; Shanghai Key Laboratory of Precision Gene Editing and Clinical Translation, Shanghai 200031, ChinaShow moreShow less
Source PDF DOI Publisher page
283 days

Engineered human iPSC-derived dendritic cells dressed with tumor MHC complexes as a cancer vaccine

Authors
Huaigeng Xu; Chisato Kamei; Deniz Gökbuget; Jacob Du; Mercedes Barrero; Li Wang; Yoshihiro Iwamoto; Jason Mark Soriano; Krystal Godding; Bo Wang; Serena S. Kwek; Gabriel I. Nistor; Hans S. Keirstead; Lawrence Fong; Shin Kaneko; Karin M.L. Gaensler; Robert BlellochShow moreShow less
Affiliations
Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, San Francisco (UCSF), San Francisco, CA, USA; Department of Urology, University of California, San Francisco (UCSF), San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco (UCSF), San Francisco, CA, USA; Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan; AIVITA Biomedical, Irvine, CA, USAShow moreShow less
Source PDF DOI Publisher page
351 days

Spatial profiling of the spleen in mouse and human myelofibrosis reveals complement-driven immune-stromal interactions as a therapeutic target

Authors
Bérénice Dugué; Pia Wanner; Mayra L. Ruiz Tejada Segura; Mohamed Saad; Lucas Greven; Katrin Götz; Carmen Schalla; Stijn Fuchs; Gerjanne Vroeg in de wei; Hélène F.E. Gleitz; Anna Katharina Galyga; Jessica Ellen Pritchard; Tobias Schlangen; Niklas Lutterbach; Salim Atakhanov; Lina Schmidt; Marie Parrens; Armelle Peyrat; Damien Luque Paz; Marie-Christine Copin; Alexandre Guy; Victor-Emmanuel Brett; Olivier Mansier; Susanne Schmitz; Paul Wanek; Bella Banjanin; Stephani Schmitz; Martina Crysandt; Marian C. Clahsen-van Groningen; Konnie M. Hebeda; Sascha Dietrich; Harald Voehringer; Matthias Meyer-Bender; Kristin Séré; Chloé James; Adam Benabid; Ivan Costa; Charles Dussiau; Rebekka K. SchneiderShow moreShow less
Affiliations
University of Bordeaux, UMR1034, Inserm, Biology of Cardiovascular Diseases, 33600 Pessac, France; RWTH Aachen University, Department of Cell and Tumor Biology, Faculty of Medicine, 52074 Aachen, Germany; RWTH Aachen University, Institute for Computational Genomics, Faculty of Medicine, Aachen 52074, Germany; Erasmus Medical Center, Department of Developmental Biology, Rotterdam 3015GD, the Netherlands; Oncode Institute, Erasmus Medical Center, Rotterdam 3015GD, the Netherlands; CHU Bordeaux, Department of Pathology, 33000 Bordeaux, France; Angers University, Nantes University, CHU Angers, Inserm, CNRS, CRCI2NA, 49000 Angers, France; CHU Angers, Department of Pathology, 49000 Angers, France; CHU Bordeaux, Laboratory of Hematology, 33000 Bordeaux, France; RWTH Aachen University, Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, 52074 Aachen, Germany; University Hospital RWTH Aachen, Department of Nephrology, 52074 Aachen, Germany; Department of Pathology and Clinical Bioinformatics, Erasmus MC Transplant Institute, Rotterdam 3015GD, the Netherlands; Laboratory for Pathology (PAL), 3318 AL Dordrecht, the Netherlands; Radboud University Medical Center, Department of Pathology, 6525 GA Nijmegen, the Netherlands; University Hospital Düsseldorf, Heinrich Heine University, Department of Hematology, Oncology and Clinical Immunology, 40225 Düsseldorf, Germany; European Molecular Biology Laboratory (EMBL), Genome Biology Unit, 69117 Heidelberg, Germany; Molecular Medicine Partnership Unit (MMPU), 69117 Heidelberg, Germany; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, 69120 Heidelberg, Germany; European Molecular Biology Laboratory, Molecular Systems Biology Unit, 69117 Heidelberg, Germany; German Cancer Research Center (DKFZ), Division of Experimental Hematology, 69120 Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), 69120 Heidelberg, GermanyShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Cell Stem Cell take to review a manuscript?

As of 2026-11-19, CrushSCI has 15 complete review records for Cell Stem Cell. The fastest paper went from submission to acceptance in 71 days (Clinical base editing for β-hemoglobinopathies across different genetic backgrounds, received 2026-06-01, accepted 2026-08-11); the slowest took 529 days. The average is 262.7 days and the median is 258 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.